Search clinical trials for: ACEI / Angiotensin converting enzyme inhibitor

Total 47078 results

Anna Posadzy-Małaczyńska

Completed

Reversal of an Unfavorable Effect of Hydrochlorothiazide Compared to Angiotensin Converting Enzyme Inhibitor on Serum Uric Acid and Oxypurines Levels by Estrogen-progestin Therapy in Hypertensive Postmenopausal Women.

Hypertension | Menopause | Hyperuricemia
Hennepin Healthcare Research Institute
American Heart Association

Completed

Cardiovascular Prevention for Persons With HIV

HIV Infection | Cardiovascular Disease Risk

United States
University Hospital Inselspital, Berne

Completed

RAS Peptide Profiles in Patients With Arterial Hypertension

Essential Hypertension

Switzerland
Wake Forest University Health Sciences

Terminated

Benazepril Hydrochloride, Lisinopril, Ramipril, or Losartan Potassium in Treating Hypertension in Patients With Solid Tumors

Hypertension | Unspecified Adult Solid Tumor, Protocol Specific

United States
Aarhus University Hospital
University of Aarhus

Completed

Intensive Vasodilator Therapy in Patients With Essential Hypertension (Vasomore)

Essential Hypertension | High Blood Pressure

Denmark
Peking University

Unknown

ACEi/ARB Alone Versus ACEi/ARB Plus Steroids in the Treatment of Primary IgA Nephropathy, a RCT

Glomerulonephritis, IGA
Shiraz University of Medical Sciences

Completed

Assessment of the Effect of Captopril Versus Combination of Captopril and Pentoxifylline on Reducing Proteinuria in Type 2 Diabetic Nephropathy

Diabetic Nephropathy

Iran, Islamic Republic of
Yining Huang

Unknown

Stratification of Blood Pressure Control Against Progress of Cerebral Small Vessel Diseases in Poststroke Patients (APPROVE)

Cerebral Small Vessel Diseases

China
Erasmus Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development

Unknown

Treatment of HYpertension: Morning Versus Evening (THYME)

Essential Hypertension

Netherlands
Institute of Cardiology, Warsaw, Poland

Terminated

Cardiovascular Magnetic Resonance for the Occluded Infarct-Related Artery Treatment (COAT)

Myocardial Infarction | Heart Diseases | Cardiovascular Diseases | Heart Failure

Poland
Vanderbilt University

Completed

Effect of DPP4 Inhibition on Vasoconstriction

Type 2 Diabetes Mellitus

United States
Catholic University, Italy

Unknown

Ramipril Versus Carvedilol in Duchenne and Becker Patients

Duchenne Muscular Dystrophy | Becker Muscular Dystrophy

Italy
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Fosinopril Sodium / Hydrochlorothiazide 20/ 12.5 mg Tablets Under Fed Conditions

Healthy

United States
Shanghai Children's Hospital

Recruiting

Study of Hydroxychloroquine in Patients With X-linked Alport Syndrome in China (CHXLAS) (CHXLAS)

Alport Syndrome, X-Linked

China
Pharmtechnology LLC
ClinPharmInvest, LLC

Completed

Bioequivalence Study of Two Formulations of Lisinopril Tablet 20 mg in Healthy Volunteers Under Fasting Conditions

Bioequivalence

Russian Federation
Daiichi Sankyo, Inc.

Completed

Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel Blocker

Hypertension

United States
Cardiology Research UBC

Terminated

Statin and Angiotensin-converting Enzyme Inhibitor on Symptoms in Patients With SCAD (SAFER-SCAD)

Coronary Artery Dissection, Spontaneous

Canada
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Benazepril HCl / Hydrochlorothiazide 20 mg/ 25 mg Tablets Under Fasting Conditions

Healthy

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Benazepril HCl / Hydrochlorothiazide 20 mg/ 25 mg Tablets Under Fed Conditions

Healthy

United States
Yonsei University
Chonbuk National University Hospital; Seoul St. Mary's Hospital; Kyungpook National... and other collaborators

Unknown

Efficacy and Safety of a Combination of Mycophenolate Mofetil and Corticosteroid in Advanced IgA Nephropathy (AIGA)

IgA Nephropathy

Korea, Republic of
Servier Russia

Completed

The Use of TrIple Fixed-dose Combination in the Treatment of Arterial Hypertension (TRICOLOR)

Arterial Hypertension

Russian Federation
NYU Langone Health

Terminated

Risk Factor Control Before Orthopedic Surgery (OPTMIZE-OS)

Cardiovascular Disease | Osteoarthritis

United States
NYU Langone Health
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University... and other collaborators

Completed

Novel Therapies for Resistant FSGS (FONTII): Phase II Clinical Trial (FONTII)

Focal Segmental Glomerulosclerosis

United States, Canada
Baylor College of Medicine

Completed

DOXAZOSIN FOR PTSD

PTSD

United States
Shenzhen Ausa Pharmed Co.,Ltd
Peking University First Hospital; Nanfang Hospital of Southern Medical University and other collaborators

Unknown

H-Type Hypertension Precision Medicine Trial

Hypertension

China
Sohag University

Recruiting

Angiotensin Converting Enzyme rs (1799752) Gene Polymorphism and Development of In-Stent Restenosis in Patients With Stable Coronary Artery Diseases in Sohag Hospital University.

Angiotensin Converting Enzyme rs (1799752) Gene Polymorphism and Development of In-Stent Restenosis in Patients With Stable Coronary Artery Diseases

Egypt
Shanghai Chest Hospital

Not yet recruiting

Cardiac Adverse Reactions Related to Immune Checkpoint Inhibitor in NSCLC Patients

Cardiac Event | Immune Checkpoint Inhibitor | Adverse Reactions | Non-Small Cell Lung Cancer Patients
Menarini International Operations Luxembourg SA

Completed

Effectiveness and Safety of Combination of Amlodipine and Zofenopril in Hypertensive Patients Versus Each Monotherapy (Masolino)

Hypertension

Hungary
Seoul National University Hospital

Completed

A Study to Investigate the Effect of Urine Acid-base Disequilibrium on the Pharmacokinetics of Captopril

Hypertension

Korea, Republic of
Novartis Pharmaceuticals

Terminated

To Study the Effects of Aliskiren on Albuminuria and Various Biomarkers in Patients With Nephropathy (ARIA)

Non-diabetic Nephropathy

Netherlands
AHEPA University Hospital
Aristotle University Of Thessaloniki

Unknown

Ramipril and Clopidogrel in Oxidative Stress, Vascular Inflammation and Endothelial Dysfunction in Type 2 Diabetes and Diabetic Nephropathy

Diabetic Nephropathy | Diabetes Type 2 | Vascular Disease

Greece
Heidelberg University
Baxter Healthcare Corporation; Boehringer Ingelheim; Aventis Pharmaceuticals; European...

Completed

Effect of Strict Blood Pressure Control and ACE-Inhibition on Progression of Chronic Renal Failure in Pediatric Patients (ESCAPE)

Hypertension | Children | Chronic Renal Failure | Acquired Kidney Disease | Congenital Kidney Disease

Czech Republic, France, Germany, Hungary, Italy, Lithuania, Poland, Portugal, Serbia, Sweden, Switzerland, Turkey
Sandoz

Completed

To Demonstrate the Relative Bioequivalence of Lisinopril 1 x 40 mg Tablets Under Fasting Conditions

Hypertension
Istituto Auxologico Italiano
European Society of Hypertension; Chinese Hypertension League

Completed

Optimal Blood Pressure and Cholesterol Targets for Preventing Recurrent Stroke in Hypertensives (ESH-CHL-SHOT)

Stroke | Hypertension | Transient Ischemic Attack

Russian Federation
Bispebjerg Hospital
University of Copenhagen; Duke University; The Ministry of Science, Technology... and other collaborators

Completed

Metabolism of Methylphenidate and Enalapril Based on CES1 Genotype

Carboxylesterase 1 (CES1) Genotype | CES1 Activity

Denmark
Assiut University

Not yet recruiting

Treatment of Patients With Diabetic Kidney Disease

Diabetic Kidney Disease
Boryung Pharmaceutical Co., Ltd

Completed

Fimasartan in the Senior Subjects (FITNESS)

The Elderly (≥ 70 Years) With Essential Hypertension

Korea, Republic of
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Fosinopril Sodium/ Hydrochlorothiazide 20/ 12.5 mg Tablets Under Fasting Conditions

Healthy

United States
Karolinska Institutet

Completed

Doxazosin and Ramipril in Hypertension (DoRa)

Hypertension

Sweden
The University of The West Indies
Caribbean Health Research Council

Unknown

Efficacy of Antioxidant Therapy Compared With Enalapril in Sickle Nephropathy

Microalbuminuria | Sickle Cell Nephropathy

Jamaica
Nantes University Hospital

Terminated

Anti-Proteinuric Response to ACEI, ARB and Diuretics Combination.

Heavy Proteinuria

France
The University of Texas Health Science Center,...
National Center for Advancing Translational Sciences (NCATS)

Completed

N-of-1 Trials In Children With Hypertension (NICHE)

Pediatric Hypertension

United States
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company

Completed

Comparison of Sevikar® and the Combination of Perindopril/Amlodipine on Central Blood Pressure

Hypertension

Spain
Nanjing First Hospital, Nanjing Medical University

Completed

Pulmonary Arterial Denervation in Patients With Pulmonary Hypertension Associated With the Left Heart Failure (PADN-5)

Pulmonary Hypertension

China
Omar Tarek Elfarargi

Not yet recruiting

Comparison Between the Efficacy of SGLT2 Inhibitor Therapy Versus ACE Inhibitor in the Treatment of Diabetic Kidney Disease (SGLT2i VS ACEi)

Diabetic Nephropathy Type 2
University of Maryland, Baltimore
King Pharmaceuticals is now a wholly owned subsidiary of Pfizer

Terminated

Mechanisms of Ramipril Reduction in the Onset of Type 2 Diabetes

Metabolic Syndrome

United States
Pfizer

Completed

A Study to Evaluate the Efficacy and Safety of Quinapril or Quinapril Plus Hydrochlorothiazide in Patients With Mild to Moderate Hypertension

Hypertension

Turkey
Novartis
Pfizer

Completed

A Study Comparing the Response of Patients With Hypertension to Amlodipine or Amlodipine Plus Benazepril.

Hypertension

United States
Novartis

Terminated

Efficacy and Safety of Aliskiren/Ramipril/Amlodipine Compared With Ramipril/Amlodipine and Aliskiren/Amlodipine in Patients With Metabolic Syndrome (ALTO)

Hypertension With Metabolic Syndrome

United Kingdom
Novartis

Completed

Effects of Amlodipine/Benazepril on Albuminuria in Hypertensive Patients With Type 2 Diabetes Mellitus

Albuminuria

Search clinical trials for: ACEI / Angiotensin converting enzyme inhibitor

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Germany

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations